Fingerprint
Dive into the research topics of 'Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti‐angiogenic effects in zebrafish model'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Vandetanib versus cabozantinib in medullary thyroid carcinoma: A focus on anti‐angiogenic effects in zebrafish model
Silvia Carra, Germano Gaudenzi, Alessandra Dicitore, Davide Saronni, Maria Celeste Cantone, Alice Plebani, Anna Ghilardi, Maria Orietta Borghi, Leo J. Hofland, Luca Persani, Giovanni Vitale*
*Corresponding author for this work
Research output: Contribution to journal › Article › Academic › peer-review
16
Citations
(Scopus)
24
Downloads
(Pure)